As evidenced by a decrease in mesenchymal markers (N-cadherin, vimentin, snail, and fibronectin) and an increase in epithelial indicators, fisetin also accelerated the phenotypic shift of melanomas from mesenchymal to epithelial (E-cadherin and desmoglein). The gene discussed is CDH2; the disease is melanoma.